Senate Health Committee Schedules Vote on FDA Commissioner Nominee Heidi Overton

Senate health committee set a vote for November 18 on President Trump's nominee Heidi Overton to become FDA commissioner.

The outcome will determine whether the nomination proceeds to the full Senate, with Democrats expected to oppose and any single Republican vote able to block it.

Committee chair Bill Cassidy expressed doubts about Overton’s role in shaping the administration’s vaccine policies, describing it as nearly disqualifying, while Senator Lisa Murkowski questioned her stance on potential vaccine restrictions.